Retatrutide — Triple Agonist Peptide

Retatrutide is one of the most advanced research peptides available. It's called a "triple agonist" because it simultaneously activates three receptors:  

🔬 What it's studied for:

• Weight loss — considered more potent than Semaglutide or Tirzepatide in research trials

• Metabolic health — improves insulin sensitivity and blood sugar regulation

• Fat reduction — targets visceral (belly) fat directly

• Liver health — studied for non-alcoholic fatty liver disease (NAFLD)

• Cardiovascular benefits — may reduce cardiovascular risk markers